KDM6A promotes hepatocellular carcinoma progression and dictates lenvatinib efficacy by upregulating FGFR4 expression.
Clin Transl Med
; 13(10): e1452, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37846441
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Liver Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Clin Transl Med
Year:
2023
Document type:
Article
Country of publication: